acetylgalactosamine has been researched along with ovalbumin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Orr, GA; Zeheb, R | 1 |
Kalay, H; Litjens, M; Saeland, E; Singh, SK; Streng-Ouwehand, I; van Kooyk, Y | 1 |
Damo, M; Hubbell, JA; Watkins, EA; Wilson, DS | 1 |
3 other study(ies) available for acetylgalactosamine and ovalbumin
Article | Year |
---|---|
Use of avidin-iminobiotin complexes for purifying plasma membrane proteins.
Topics: Acetylgalactosamine; Avidin; Biotin; Cell Membrane; Galactose; Galactose Oxidase; Indicators and Reagents; Membrane Proteins; Ovalbumin; Sialic Acids | 1986 |
Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses.
Topics: Acetylgalactosamine; Animals; Antigen Presentation; Antigens, Tumor-Associated, Carbohydrate; Blotting, Western; Bone Marrow Cells; CD8-Positive T-Lymphocytes; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Cross-Priming; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glycosylation; Histocompatibility Antigens Class I; Lectins, C-Type; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Differentiation Factor 88; Ovalbumin; Receptors, Antigen, T-Cell; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen | 2011 |
Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8
Topics: Acetylgalactosamine; Adoptive Transfer; Animals; Antigen Presentation; Antigens; ATP Binding Cassette Transporter, Subfamily B, Member 2; CD8-Positive T-Lymphocytes; Cells, Cultured; Cross-Priming; Hepatocytes; Immune Tolerance; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Ovalbumin; Skin Transplantation; Solubility; Vesicular Transport Proteins | 2021 |